We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Keurig Dr Pepper Inc. (KDP - Free Report) came out with second-quarter 2024 results, wherein both the top and bottom lines improved year over year, and sales came ahead of the Zacks Consensus Estimate. Shares of KDP were up more than 3% in the pre-market trading session on Jul 25.
The second-quarter show reflected accelerating net sales trends, considerable margin growth and solid earnings improvement. Robust execution drove the company's performance as it continued to pursue its long-term strategic goals.
Keurig Dr Pepper is benefiting from its consumer-centric innovation model, portfolio expansion into higher growth categories and efforts to strengthen an already strong route-to-market. These endeavors are supported by a constant focus on cost efficiency and capital discipline. KDP is on track to meet its reaffirmed full-year view, alongside initiating projects to sustain growth over multiple years.
Quarter in Detail
Adjusted earnings of 45 cents per share grew 7.1% year over year and came in line with the Zacks Consensus Estimate. The bottom-line growth resulted from a robust operating income increase and a reduced share count, partly negated by an elevated tax rate and interest expenses.
Keurig Dr Pepper, Inc Price, Consensus and EPS Surprise
Net sales of $3,922 million surpassed the Zacks Consensus Estimate of $3,901 million and increased 3.5% year over year. On a constant-currency basis, net sales improved 3.4%, backed by the higher volume/mix (up 1.8%) and increased net price realization (up 1.6%). Sales were fueled by strength in the International and the U.S. Refreshment Beverages segments.
The adjusted gross profit rose 4.6% year over year to $2,172 million, with the adjusted gross margin expanding 130 basis points (bps) to 56.1%.
The adjusted operating income rose 11% year over year to $970 million in the quarter due to improved net price realization and net productivity. Meanwhile, the adjusted operating margin expanded 170 bps year over year to 24.7%.
Segmental Details
Sales in the U.S. Refreshment Beverages segment totaled $2,407 million, up 3.3% year over year, reflecting 2.9% higher net price realization, and 0.4% growth in volume/mix. The volume/mix improvement benefited from expanded scale from recent collaborations and in-market strength from launched innovation.
Sales in the U.S. Coffee segment declined 2.1% year over year to $950 million, reflecting a net price decrease of 2.9%, somewhat compensated by a volume/mix improvement of 0.8%. The company witnessed a marginal 0.2% year-over-year increase in K-pod shipments on robust market share trends across its owned and licensed portfolio. Brewer shipments totaled 10.1 million in the 12 months ending Jun 30, 2024, up 1.4% year over year, driven by continued strength in Keurig's market share.
Sales in the International segment advanced 15.5% year over year to $565 million. On a constant-currency basis, the segment’s net sales jumped 14.7%, gaining from a favorable net price realization of 4.3% and a volume/mix rise of 10.4%. The segment witnessed broad-based portfolio strength.
Other Financials
As of Jun 30, 2024, Keurig Dr Pepper’s cash and cash equivalents were $438 million. KDP had long-term obligations of $12,406 million and total stockholders’ equity of $24,718 million.
Net cash provided by operating activities totaled $742 million for the first six months of 2024, with the free cash flow amounting to $470 million.
Guidance
Keurig Dr Pepper reiterated its 2024 guidance. The company expects 2024 constant-currency net sales growth in the mid-single digits. It continues to envision adjusted earnings per share growth in the high-single digits.
Shares of this currently Zacks Rank #4 (Sell) company have declined 2.8% in the past three months compared to the industry’s 0.2% rise.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales and earnings indicates growth of 24.8% and 177.1%, respectively, from the prior-year reported level.
BRF (BRFS - Free Report) , which engages in raising, producing and slaughtering poultry and pork for processing, production and sale of fresh meat, processed products, pasta, margarine, pet food and other products, currently sports a Zacks Rank #1.
The Zacks Consensus Estimate for BRF’s current financial-year sales and earnings suggests growth of 7.5% and 210%, respectively, from the year-ago reported figures.
Vital Farms (VITL - Free Report) , which provides pasture-raised products, currently sports a Zacks Rank #1. The Zacks Consensus Estimate for Vital Farms’ current financial-year sales and earnings indicates growth of 22.6% and 64.4%, respectively, from the prior-year reported level.
VITL has a trailing four-quarter average earnings surprise of 102.1%.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Keurig (KDP) Q2 Earnings Meet Estimates, Volumes Drive Sales
Keurig Dr Pepper Inc. (KDP - Free Report) came out with second-quarter 2024 results, wherein both the top and bottom lines improved year over year, and sales came ahead of the Zacks Consensus Estimate. Shares of KDP were up more than 3% in the pre-market trading session on Jul 25.
The second-quarter show reflected accelerating net sales trends, considerable margin growth and solid earnings improvement. Robust execution drove the company's performance as it continued to pursue its long-term strategic goals.
Keurig Dr Pepper is benefiting from its consumer-centric innovation model, portfolio expansion into higher growth categories and efforts to strengthen an already strong route-to-market. These endeavors are supported by a constant focus on cost efficiency and capital discipline. KDP is on track to meet its reaffirmed full-year view, alongside initiating projects to sustain growth over multiple years.
Quarter in Detail
Adjusted earnings of 45 cents per share grew 7.1% year over year and came in line with the Zacks Consensus Estimate. The bottom-line growth resulted from a robust operating income increase and a reduced share count, partly negated by an elevated tax rate and interest expenses.
Keurig Dr Pepper, Inc Price, Consensus and EPS Surprise
Keurig Dr Pepper, Inc price-consensus-eps-surprise-chart | Keurig Dr Pepper, Inc Quote
Net sales of $3,922 million surpassed the Zacks Consensus Estimate of $3,901 million and increased 3.5% year over year. On a constant-currency basis, net sales improved 3.4%, backed by the higher volume/mix (up 1.8%) and increased net price realization (up 1.6%). Sales were fueled by strength in the International and the U.S. Refreshment Beverages segments.
The adjusted gross profit rose 4.6% year over year to $2,172 million, with the adjusted gross margin expanding 130 basis points (bps) to 56.1%.
The adjusted operating income rose 11% year over year to $970 million in the quarter due to improved net price realization and net productivity. Meanwhile, the adjusted operating margin expanded 170 bps year over year to 24.7%.
Segmental Details
Sales in the U.S. Refreshment Beverages segment totaled $2,407 million, up 3.3% year over year, reflecting 2.9% higher net price realization, and 0.4% growth in volume/mix. The volume/mix improvement benefited from expanded scale from recent collaborations and in-market strength from launched innovation.
Sales in the U.S. Coffee segment declined 2.1% year over year to $950 million, reflecting a net price decrease of 2.9%, somewhat compensated by a volume/mix improvement of 0.8%. The company witnessed a marginal 0.2% year-over-year increase in K-pod shipments on robust market share trends across its owned and licensed portfolio. Brewer shipments totaled 10.1 million in the 12 months ending Jun 30, 2024, up 1.4% year over year, driven by continued strength in Keurig's market share.
Sales in the International segment advanced 15.5% year over year to $565 million. On a constant-currency basis, the segment’s net sales jumped 14.7%, gaining from a favorable net price realization of 4.3% and a volume/mix rise of 10.4%. The segment witnessed broad-based portfolio strength.
Other Financials
As of Jun 30, 2024, Keurig Dr Pepper’s cash and cash equivalents were $438 million. KDP had long-term obligations of $12,406 million and total stockholders’ equity of $24,718 million.
Net cash provided by operating activities totaled $742 million for the first six months of 2024, with the free cash flow amounting to $470 million.
Guidance
Keurig Dr Pepper reiterated its 2024 guidance. The company expects 2024 constant-currency net sales growth in the mid-single digits. It continues to envision adjusted earnings per share growth in the high-single digits.
Shares of this currently Zacks Rank #4 (Sell) company have declined 2.8% in the past three months compared to the industry’s 0.2% rise.
3 Staple Bets Looking Good
Freshpet, Inc. (FRPT - Free Report) , a pet food company, has a trailing four-quarter earnings surprise of 118.2%, on average. FRPT currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Freshpet’s current financial-year sales and earnings indicates growth of 24.8% and 177.1%, respectively, from the prior-year reported level.
BRF (BRFS - Free Report) , which engages in raising, producing and slaughtering poultry and pork for processing, production and sale of fresh meat, processed products, pasta, margarine, pet food and other products, currently sports a Zacks Rank #1.
The Zacks Consensus Estimate for BRF’s current financial-year sales and earnings suggests growth of 7.5% and 210%, respectively, from the year-ago reported figures.
Vital Farms (VITL - Free Report) , which provides pasture-raised products, currently sports a Zacks Rank #1. The Zacks Consensus Estimate for Vital Farms’ current financial-year sales and earnings indicates growth of 22.6% and 64.4%, respectively, from the prior-year reported level.
VITL has a trailing four-quarter average earnings surprise of 102.1%.